Quantification using a GPNMB-specific sandwich ELISA revealed that TBS-soluble GPNMB protein levels tended to be increased in AD patients in comparison to non-demented control individuals, but the difference did not reach statistical significance (p = 0.06; Fig. 6g). The gene discussed is GPNMB; the disease is Alzheimer disease.